non-small cell lung cancerscreeningtargeted therapyimmunotherapyepidermal growth factor receptor(EGFR)mutationprogrammed cell death protein 1(PD-1)programmed deathligand 1(PD-L1)clinical trialsclinical guidelinesIn China,lung cancer is a primary cancer type with high incidence and mortality.Risk factors fo...
Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is responsible for the majority of cancer-related deaths worldwide. The management of NSCLC has improved considerably, especially in the past 10 years. The systematic screeni
Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is responsible for the majority of cancer-related deaths worldwide. The management of NSCLC has improved considerably, especially in the past 10 years. The systematic screeni
Non-small cell lung cancer (NSCLC) is the main subtype of lung cancer, and pemetrexed (PEM) resistance limits its treatment[20]. Multiple studies showed that HDAC1, which can regulate H3K18cr in cancer development, was upregulated in clinical NSCLC tissues and correlated with poo...
Small CellNNLCCuCCngNNTGGabuuliieddeeolliifnnCeeossnIInnteddneetxxs StagingN,SDCisLcCusTsaiobnle, oRDfeiCsfecorunestnescnioetnss NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Non-Small Cell Lung Cancer Version 2.2013 NCCN.org NCCN Guidelines for Patients™ available at www...
Lung cancer is one of the most frequently diagnosed cancers and is the leading cause of cancer-related death worldwide. Non-small-cell lung cancer (NSCLC), a heterogeneous class of tumours, represents approximately 85% of all new lung cancer diagnoses. T
In North America, lung cancer has become more predominant among former than current smokers. Yet in some countries, such as China, which has experienced a dramatic increase in the cigarette smoking rate during the past 2 decades, a peak in lung cancer incidence is still expected. Approximately ...
Impact of family history of cancer on the incidence of mutation in epidermal growth factor receptor gene in non-small cell lung cancer patients Lung Cancer, 81 (2013), pp. 162-166 View PDFView articleView in ScopusGoogle Scholar 7 Y. He, Y. Wang, T. Boyle, et al. Hepatic metastases ...
Plevritis, PhD JAMA Oncology Key Points Question What do the latest US data reveal about non–small cell lung cancer (NSCLC) epidemiology? Findings In this cross-sectional epidemiological analysis, NSCLC incidence decreased from 2010 to 2017 overall, but rose for patients with stage I disease. ...
Lung cancer is still the leading cause of cancer-related mortality. Over the past two decades, the management of non-small cell lung cancer (NSCLC) has undergone a significant revolution. Since the first identification of activating mutations in the epid